company background image
A249420 logo

Ildong Pharmaceutical KOSE:A249420 Stock Report

Last Price

₩13.62k

Market Cap

₩380.7b

7D

-0.5%

1Y

-17.9%

Updated

31 Oct, 2024

Data

Company Financials +

Ildong Pharmaceutical Co., Ltd.

KOSE:A249420 Stock Report

Market Cap: ₩380.7b

A249420 Stock Overview

Develops, manufactures, and sells pharmaceutical products in South Korea.

A249420 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Ildong Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ildong Pharmaceutical
Historical stock prices
Current Share Price₩13,620.00
52 Week High₩20,500.00
52 Week Low₩11,980.00
Beta0.93
11 Month Change-1.87%
3 Month Change-1.45%
1 Year Change-17.90%
33 Year Change-7.35%
5 Year Change-23.11%
Change since IPO-28.47%

Recent News & Updates

Revenues Not Telling The Story For Ildong Pharmaceutical Co., Ltd. (KRX:249420) After Shares Rise 33%

Aug 20
Revenues Not Telling The Story For Ildong Pharmaceutical Co., Ltd. (KRX:249420) After Shares Rise 33%

Is Ildong Pharmaceutical (KRX:249420) A Risky Investment?

Aug 12
Is Ildong Pharmaceutical (KRX:249420) A Risky Investment?

Recent updates

Revenues Not Telling The Story For Ildong Pharmaceutical Co., Ltd. (KRX:249420) After Shares Rise 33%

Aug 20
Revenues Not Telling The Story For Ildong Pharmaceutical Co., Ltd. (KRX:249420) After Shares Rise 33%

Is Ildong Pharmaceutical (KRX:249420) A Risky Investment?

Aug 12
Is Ildong Pharmaceutical (KRX:249420) A Risky Investment?

If You Had Bought Ildong Pharmaceutical (KRX:249420) Shares A Year Ago You'd Have Earned 18% Returns

Jan 01
If You Had Bought Ildong Pharmaceutical (KRX:249420) Shares A Year Ago You'd Have Earned 18% Returns

Shareholder Returns

A249420KR PharmaceuticalsKR Market
7D-0.5%-1.9%-0.4%
1Y-17.9%32.0%10.4%

Return vs Industry: A249420 underperformed the KR Pharmaceuticals industry which returned 32% over the past year.

Return vs Market: A249420 underperformed the KR Market which returned 10.4% over the past year.

Price Volatility

Is A249420's price volatile compared to industry and market?
A249420 volatility
A249420 Average Weekly Movement8.7%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement6.7%
10% most volatile stocks in KR Market12.2%
10% least volatile stocks in KR Market3.6%

Stable Share Price: A249420 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A249420's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19411,020Yun Paul Woongsupwww.ildong.com

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system applications. It also provides raw material drugs; health foods and foods; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products.

Ildong Pharmaceutical Co., Ltd. Fundamentals Summary

How do Ildong Pharmaceutical's earnings and revenue compare to its market cap?
A249420 fundamental statistics
Market cap₩380.72b
Earnings (TTM)-₩48.68b
Revenue (TTM)₩603.86b

0.6x

P/S Ratio

-7.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A249420 income statement (TTM)
Revenue₩603.86b
Cost of Revenue₩383.79b
Gross Profit₩220.07b
Other Expenses₩268.75b
Earnings-₩48.68b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.74k
Gross Margin36.44%
Net Profit Margin-8.06%
Debt/Equity Ratio113.1%

How did A249420 perform over the long term?

See historical performance and comparison